{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:57:49Z","timestamp":1785592669562,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10096-026-05525-1","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:18:40Z","timestamp":1777342720000},"page":"2429-2436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Maternal early primary CMV infection with negative or equivocal CMV IgM"],"prefix":"10.1007","volume":"45","author":[{"given":"Vincent","family":"Portet Sulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rafek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Bouthry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Simas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Jadaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Mouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Perillaud-Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Vauloup-Fellous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"1","key":"5525_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2458-5-70","volume":"5","author":"MJ Cannon","year":"2005","unstructured":"Cannon MJ, Davis KF (2005) Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5(1):70. https:\/\/doi.org\/10.1186\/1471-2458-5-70","journal-title":"BMC Public Health"},{"issue":"4","key":"5525_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253\u2013276. https:\/\/doi.org\/10.1002\/rmv.535PubMed PMID: 17579921","journal-title":"Rev Med Virol"},{"issue":"2","key":"5525_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jcv","volume":"35","author":"RF Pass","year":"2006","unstructured":"Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35(2):216\u2013220. https:\/\/doi.org\/10.1016\/j.jcv2005.09.015 PubMed PMID: 16368262","journal-title":"J Clin Virol"},{"issue":"8","key":"5525_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/pd.4118","volume":"33","author":"O Picone","year":"2013","unstructured":"Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, Fuchs F et al (2013) A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 33(8):751\u2013758. https:\/\/doi.org\/10.1002\/pd.4118PubMed PMID: 23553686","journal-title":"Prenat Diagn"},{"issue":"6","key":"5525_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","volume":"223","author":"C Chatzakis","year":"2020","unstructured":"Chatzakis C, Ville Y, Makrydimas G, Dinas K, Zavlanos A, Sotiriadis A (2020) Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol 223(6):870\u2013883e11. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.038PubMed PMID: 32460972","journal-title":"Am J Obstet Gynecol"},{"issue":"10253","key":"5525_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0140-6736(","volume":"396","author":"K Shahar-Nissan","year":"2020","unstructured":"Shahar-Nissan K, Pardo J, Peled O, Krause I, Bilavsky E, Wiznitzer A et al (2020) Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet 396(10253):779\u2013785. https:\/\/doi.org\/10.1016\/S0140-6736(20)31868-7 PubMed PMID: 32919517","journal-title":"Lancet"},{"issue":"2","key":"5525_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","volume":"230","author":"C Chatzakis","year":"2024","unstructured":"Chatzakis C, Shahar-Nissan K, Faure-Bardon V, Picone O, Hadar E, Amir J et al (2024) The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis. Am J Obstet Gynecol 230(2):109\u2013117e2. https:\/\/doi.org\/10.1016\/j.ajog.2023.07.022PubMed PMID: 37473793","journal-title":"Am J Obstet Gynecol"},{"key":"5525_CR8","doi-asserted-by":"publisher","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","volume":"40","author":"M Leruez-Ville","year":"2024","unstructured":"Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N et al (2024) Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg Health Eur 40:100892. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100892PubMed PMID: 38590940; PubMed Central PMCID: PMC10999471","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"5525_CR9","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1007\/s10096-012-1700-0","volume":"31","author":"MG Revello","year":"2012","unstructured":"Revello MG, Vauloup-Fellous C, Grangeot-Keros L, van Helden J, Dickstein Y, Lipkin I et al (2012) Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(\u00ae) analyser platform. Eur J Clin Microbiol Infect Dis 31(12):3331\u20133339. https:\/\/doi.org\/10.1007\/s10096-012-1700-0PubMed PMID: 22850741","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"5525_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/CVI.00106-14","volume":"21","author":"HE Prince","year":"2014","unstructured":"Prince HE, Lap\u00e9-Nixon M, Brenner A, Pitstick N, Couturier MR (2014) Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity. Clin Vaccine Immunol 21(6):813\u2013816. https:\/\/doi.org\/10.1128\/CVI.00106-14PubMed PMID: 24671558; PubMed Central PMCID: PMC4054234","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"5525_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/diagnostics11030396","volume":"11","author":"A Sarasini","year":"2021","unstructured":"Sarasini A, Arossa A, Zavattoni M, Fornara C, Lilleri D, Spinillo A et al (2021) Pitfalls in the Serological Diagnosis of Primary Human Cytomegalovirus Infection in Pregnancy Due to Different Kinetics of IgM Clearance and IgG Avidity Index Maturation. Diagnostics (Basel) 11(3):396. https:\/\/doi.org\/10.3390\/diagnostics11030396PubMed PMID: 33652709; PubMed Central PMCID: PMC7996894","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"5525_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jcv.2012.10.017","volume":"56","author":"C Vauloup-Fellous","year":"2013","unstructured":"Vauloup-Fellous C, Berth M, Heskia F, Dugua JM, Grangeot-Keros L (2013) Re-evaluation of the VIDAS(\u00ae) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J Clin Virol 56(2):118\u2013123. https:\/\/doi.org\/10.1016\/j.jcv.2012.10.017PubMed PMID: 23182774","journal-title":"J Clin Virol"},{"issue":"2","key":"5525_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcv.2012.09.015","volume":"56","author":"G Enders","year":"2013","unstructured":"Enders G, Daiminger A, B\u00e4der U, Exler S, Schimpf Y, Enders M (2013) The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. J Clin Virol 56(2):102\u2013107. https:\/\/doi.org\/10.1016\/j.jcv.2012.09.015","journal-title":"J Clin Virol"},{"issue":"4","key":"5525_CR14","doi-asserted-by":"publisher","first-page":"e0140723","DOI":"10.1128\/jcm.01407-23","volume":"62","author":"A Daiminger","year":"2024","unstructured":"Daiminger A, Beck R, Exler S, Bartelt U, Enders M (2024) Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy - no test fits all needs. J Clin Microbiol 62(4):e0140723. https:\/\/doi.org\/10.1128\/jcm.01407-23PubMed PMID: 38426762; PubMed Central PMCID: PMC11005438","journal-title":"J Clin Microbiol"},{"key":"5525_CR15","doi-asserted-by":"publisher","first-page":"105614","DOI":"10.1016\/j.jcv.2023.105614","volume":"169","author":"J Fourgeaud","year":"2023","unstructured":"Fourgeaud J, Nguyen C\u00c2, Guilleminot T, Ville Y, Leruez-Ville M (2023) Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy. J Clin Virol 169:105614. https:\/\/doi.org\/10.1016\/j.jcv.2023.105614PubMed PMID: 37982548","journal-title":"J Clin Virol"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05525-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:11:42Z","timestamp":1785589902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05525-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5525"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05525-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As part of routine care in our hospital, patients are informed that, unless they formally object, their medical data may be used for research purposes. No patient objected. All data were analyzed anonymously. Given the retrospective design and the use of anonymized routine-care data, formal written informed consent was not required. The study was conducted in accordance with the Declaration of Helsinki and with the applicable French regulations.","order":1,"name":"Ethics","label":"Ethics approval and patient co<b>nsent<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}